Birmingham to lead ground-breaking research into patient experience of cell therapies

Birmingham health researchers, with industry partners including health technology companies Dignio and Datatrial, have been awarded £1.1 million by UK Research & Innovation (UKRI)’s Innovate UK, to investigate patients’ experience of cell and gene therapies. The funding has been provided as part of the Industrial Strategy Challenge Fund’s Medicines Manufacturing programme. Cell and gene therapies … Continue reading “Birmingham to lead ground-breaking research into patient experience of cell therapies”

Birmingham to lead brain cancer study in memory of Tessa Jowell

Significant funding of up to £2.8m from The Brain Tumour Charity has been awarded to a Birmingham researcher for a major study named in memory of the late Baroness Jowell. The Tessa Jowell BRAIN-MATRIX trial is being co-ordinated by Professor Colin Watts (pictured) of the Institute of Cancer and Genomic Sciences, part of the University of … Continue reading “Birmingham to lead brain cancer study in memory of Tessa Jowell”

Expert warns over little room for complacency over fall in twin stillbirth rates

A leading expert in fetal medicine at the University of Birmingham has warned that there is ‘little room for complacency’ over a fall in twin stillbirth rates as the reason for this phenomenon are complex. In a paper published today (November 27th 2018) in BJOG: An International Journal of Obstetrics & Gynaecology, Mark Kilby, Professor … Continue reading “Expert warns over little room for complacency over fall in twin stillbirth rates”

Integrated COPD study sees hospitals and GPs working together

Hundreds of patients with chronic obstructive pulmonary disease (COPD) have been recruited to a pioneering study featuring collaboration between primary and secondary care. Led by Heartlands Hospital, part of BHP founder member University Hospitals Birmingham NHS Foundation Trust (UHB), the study has rolled out across all GP practices in Birmingham. Over 700 patients have already … Continue reading “Integrated COPD study sees hospitals and GPs working together”

New partner announced as part of lung cancer research

Mirati Therapeutics, Inc. has been announced as the latest partner of Cancer Research UK’s Stratified Medicine Programme which is being carried out in collaboration with the University of Birmingham Cancer Research Clinical Trials Unit. The partnership will make Mirati’s experimental drug, sitravatinib, available for inclusion in the programme through the National Lung Matrix Trial – … Continue reading “New partner announced as part of lung cancer research”